Refine your search
24 trials found for Lung Neoplasm, Lung Carcinoma, Lung cancer
All(24)
Recruiting(19)
Not yet recruiting(5)
Mar 05, 2025 - Planned start date (Not yet recruiting)
nct06870487
a study to learn about the study medicine called pf-08046032 in people with advanced cancers.
peripheral t cell lymphoma, diffuse large b-cell lymphoma, classical hodgkin lymphoma, head and neck squamous cell carcinoma, melanoma, non-small cell lung cancer
all
18+ years
1study location(s)
Nov 29, 2024 - Planned start date (Not yet recruiting)
nct06487078
analysis of the effectiveness and safety of lorlatinib in untreated alk-positive nsclc patients in a french real-world context
alk+ non-small-cell lung carcinoma
all
18+ years
1study location(s)
Dec 31, 2024 - Planned start date (Not yet recruiting)
NCT06678555
A Study to Learn About Lorlatinib in Patients With Non-Small Cell Lung Cancer (NSCLC) Which Has Spread Out.
Carcinoma, Non-Small-Cell Lung
Male or Female
18 - 99 years
1study location(s)
May 16, 2025 - Planned start date (Not yet recruiting)
nct04889495
a post-marketing surveillance to assess the safety and effectiveness of zirabev in domestic patients with various cancer
non-small cell lung cancer, metastatic colorectal cancer, metastatic breast cancer, metastatic kidney cancer, cervical cancer, epithelial ovarian cancer, fallopian tube cancer, primary peritoneal cancer
all
19+ years
1study location(s)
Saved trials
Saved trials
You currently don’t have any saved trials. To save a trial, select the bookmark icon on the result listing.
All(24)
Recruiting(19)
Not yet recruiting(5)
Contact us
For more information about participation in a Pfizer clinical trial, please email or call the Pfizer Clinical Trial Contact Center at 1-800-887-7002.